{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:20:59Z","timestamp":1790371259810,"version":"4.1.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00142","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T04:22:15Z","timestamp":1583814135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids"],"prefix":"10.3389","volume":"11","author":[{"given":"Federica","family":"Bortone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Scandiffio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Marcuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Frangiamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresio","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0000000000000647","article-title":"Diagnosis and treatment of myasthenia gravis","volume":"31","author":"Mantegazza","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1756285617749134","DOI":"10.1177\/1756285617749134","article-title":"When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies","volume":"11","author":"Mantegazza","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1474-4422(18)30467-8","article-title":"Thymectomy in myasthenia gravis: when, why, and how?","volume":"18","author":"Berrih-Aknin","year":"2019","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"MGTX study group. Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"MGTX Study Group. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","volume":"18","author":"Wolfe","year":"2019","journal-title":"Lancet Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","volume":"1412","author":"Cron","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J Autoimmun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","article-title":"Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection","volume":"221","author":"Cavalcante","year":"2016","journal-title":"Immunobiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/nyas.13534","article-title":"Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?","volume":"1413","author":"Cavalcante","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12016-016-8549-4","article-title":"Review on Toll-like receptor activation in myasthenia gravis: application to the development of new experimental models","volume":"52","author":"Robinet","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12943-018-0765-5","article-title":"Nuclear functions of mammalian microRNAs in gene regulation, immunity and cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fonc.2019.00920","article-title":"The emerging role of major regulatory RNAs in cancer control","volume":"9","author":"Dai","year":"2019","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in autoimmunity and autoimmune diseases","volume":"32","author":"Pauley","year":"2009","journal-title":"J Autoimmun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","article-title":"The role of miRNA in inflammation and autoimmunity","volume":"12","author":"Singh","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","article-title":"MicroRNA-146a: a dominant, negative regulator of the innate immune response","volume":"5","author":"Saba","year":"2014","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/gene.2011.84","article-title":"Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene","volume":"13","author":"L\u00f6fgren","year":"2012","journal-title":"Genes Immun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar2493","article-title":"Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Pauley","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.autrev.2015.07.005","article-title":"MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential","volume":"14","author":"Churov","year":"2015","journal-title":"Autoimm Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7150\/ijms.8647","article-title":"Expression, regulation and function of microRNAs in multiple sclerosis","volume":"11","author":"Ma","year":"2014","journal-title":"Int J Med Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.7754\/Clin.Lab.2016.160511","article-title":"The prognostic value of plasma microRNA-155 and microRNA-146a level in severe sepsis and sepsis-induced acute lung injury patients","volume":"62","author":"Han","year":"2016","journal-title":"Clin Lab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cyto.2014.09.003","article-title":"Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology","volume":"71","author":"Zhou","year":"2015","journal-title":"Cytokine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1152\/physiolgenomics.00133.2016","article-title":"miR-146a\/b: a family with shared seeds and different roots","volume":"49","author":"Paterson","year":"2017","journal-title":"Physiol Genomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NFkappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1084\/jem.20132613","article-title":"Germinal center B cell maintenance and differentiation are controlled by distinct NF-\u03baB transcription factor subunits","volume":"211","author":"Heise","year":"2014","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1172\/JCI94012","article-title":"miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity","volume":"127","author":"Li","year":"2017","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1038\/s41467-018-05196-3","article-title":"Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b","volume":"9","author":"Cho","year":"2018","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1038\/ncomms7436","article-title":"MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres","volume":"6","author":"Pratama","year":"2015","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1182\/blood-2012-08-452425","article-title":"Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells","volume":"121","author":"Guo","year":"2013","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neulet.2013.09.014","article-title":"Altered expression of miR-146a in myasthenia gravis","volume":"555","author":"Lu","year":"2013","journal-title":"Neurosci Lett"},{"key":"B36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imm.12347","article-title":"Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis","volume":"144","author":"Zhang","year":"2015","journal-title":"Immunology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jaci.2011.12.001","article-title":"Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients","volume":"129","author":"Goleva","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1211\/0022357011775857","article-title":"Comparison of suppressive potency between prednisolone and prednisolone sodium succinate against mitogen-induced blastogenesis of human peripheral blood mononuclear cells in-vitro","volume":"53","author":"Sugiyama","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S1567-5769(02)00077-2","article-title":"Immunosuppressant pharmacodynamics on peripheral-blood mononuclear cells from patients with ulcerative colitis","volume":"2","author":"Hirano","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"659028","DOI":"10.1155\/2009\/659028","article-title":"Quantification of small non-coding RNAs allows an accurate comparison of miRNA expression profiles","volume":"2009","author":"Masotti","year":"2009","journal-title":"J Biomed Biotechnol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"19529","DOI":"10.1038\/srep19529","article-title":"Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material","volume":"6","author":"El-Khoury","year":"2016","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035 cases and a critical review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20051450","article-title":"Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8\/IFN consensus sequence-binding protein","volume":"203","author":"Lee","year":"2006","journal-title":"J Exp Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1097\/PAS.0b013e318166f46a","article-title":"Expression of the interferon regulatory factor 8\/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker","volume":"32","author":"Martinez","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jns.2015.06.019","article-title":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients","volume":"356","author":"Punga","year":"2015","journal-title":"J Neurol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s11481-013-9498-9","article-title":"Identification of novel microRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response","volume":"8","author":"Wang","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fimmu.2019.00539","article-title":"Causes and consequences of miR-150-5p dysregulation in myasthenia gravis","volume":"10","author":"Cron","year":"2019","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.imbio.2016.06.012","article-title":"A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients","volume":"221","author":"Barzago","year":"2016","journal-title":"Immunobiology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.autrev.2018.01.008","article-title":"Analysis of microRNA expression in the thymus of myasthenia gravis patients opens new research avenues","volume":"17","author":"Cron","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.3390\/ncrna3030022","article-title":"miR-146 and miR-155: two key modulators of immune response and tumor development","volume":"3","author":"Testa","year":"2017","journal-title":"Noncoding RNA"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-155 is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell-free miR-146a and miR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.016","article-title":"Central role of interferon-beta in thymic events leading to myasthenia gravis","volume":"52","author":"Cufi","year":"2014","journal-title":"J Autoimmun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/leu.2012.108","article-title":"Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2","volume":"26","author":"Rosato","year":"2012","journal-title":"Leukemia"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/annrheumdis-2013-204377","article-title":"Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis","volume":"74","author":"Zhou","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-\u03b1","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J Autoimmun"},{"key":"B60","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e113842","DOI":"10.1371\/journal.pone.0113842","article-title":"Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells","volume":"9","author":"Palagani","year":"2014","journal-title":"PLoS ONE"},{"key":"B62","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.immuni.2008.07.016","article-title":"Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis","volume":"29","author":"Hao","year":"2008","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1074\/jbc.M114.591420","article-title":"MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins","volume":"290","author":"Park","year":"2015","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/gtmb.2011.0026","article-title":"microRNA 146a expression in rheumatoid arthritis: association with tumor necrosis factor-alpha and disease activity","volume":"15","author":"Abou-Zeid","year":"2011","journal-title":"Genet Test Mol Biomark"},{"key":"B65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1471-2474-11-209","article-title":"microRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients","volume":"11","author":"Niimoto","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"B66","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/nyas.13591","article-title":"An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients","volume":"1413","author":"Villegas","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2011.08.021","article-title":"Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis","volume":"504","author":"Fenoglio","year":"2011","journal-title":"Neurosci Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T04:22:18Z","timestamp":1583814138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2020.00142"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00142","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"article-number":"142"}}